Sort
39,280 grants matching “leukemia”
Development of Therapeutic CD59 inhibitor for treating B-cell malignancies
$327,938Xuebin Qin · Temple Univ Of The Commonwealth · R01 · FY2016 · CA
DEPSIPEPTIDE: A NOVEL HISTONE DEACYTLASE INHIBITOR IN L
$327,910Ohio State University · R21 · FY2002 · CA
Determination of the mechanism of lenalidomide activity in acute myeloid leukemia
$327,887Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2015 · CA
Determination of the mechanism of lenalidomide activity in acute myeloid leukemia
$327,877Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2016 · CA
Development of Therapeutic CD59 inhibitor for treating B-cell malignancies
$327,872Xuebin Qin · Temple Univ Of The Commonwealth · R01 · FY2015 · CA
Function and Biology of Eukaryotic DNA Topoisomerases
$327,872Neil Osheroff · Vanderbilt University · R01 · FY2007 · GM
Determination of the mechanism of lenalidomide activity in acute myeloid leukemia
$327,867Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2017 · CA
Oncogene-Induced Evasion from Apoptosis
$327,860Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2006 · CA
Determination of the mechanism of lenalidomide activity in acute myeloid leukemia
$327,858Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2018 · CA
Regulation of metastasis and epithelial-mesenchymal transition by microRNAs
$327,850Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
$327,850Wenwei Hu · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
Regulation of metastasis and epithelial-mesenchymal transition by microRNAs
$327,850Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Characterization of a T cell dysfunctional state induced in mice with AML
$327,850Justin P. Kline · University Of Chicago · R01 · FY2016 · CA
Regulation of metastasis and epithelial-mesenchymal transition by microRNAs
$327,850Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Characterization of a T cell dysfunctional state induced in mice with AML
$327,850Justin P. Kline · University Of Chicago · R01 · FY2015 · CA
The role and functional mechanism of TET1 in MLL-rearranged leukemia
$327,850Jianjun Chen · University Of Cincinnati · R01 · FY2016 · CA
Sapacitabine therapy to create synthetic lethality in DNA repair-deficient CLL
$327,850William George Wierda · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
JAK-STAT signaling during CNS development
$327,822University Of California Los Angeles · R01 · FY2004 · MH
Determination of the mechanism of lenalidomide activity in acute myeloid leukemia
$327,796Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2014 · CA
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
$327,794Rui Lu · University Of Alabama At Birmingham · R01 · FY2024 · CA
Deciphering the molecular mechanisms of TNT formation and function using a multi-omic approach
$327,770Karine Gousset · California State University Fresno · SC1 · FY2021 · GM
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
$327,765Ravindra Majeti · Stanford University · R01 · FY2016 · CA
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
$327,755Matthew J Walter · Washington University · P50 · FY2022 · CA
Study DNA repair in preventing MDS and AML after radiation and benzene exposure
$327,726Edward P Hasty · University Of Texas Hlth Science Center · R01 · FY2013 · ES
Mechanisms of Hox Gene Regulation By MLL
$327,722University Of Pennsylvania · R01 · FY2003 · CA